McKesson Corp.

  • Market Cap: Large Cap
  • Industry: Retailing
  • ISIN: US58155Q1031
USD
813.80
-1.74 (-0.21%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About McKesson Corp. stock-summary
stock-summary
McKesson Corp.
Retailing
McKesson Corporation is a healthcare supply chain management solution, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through three segments: United States Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions and Medical-Surgical Solutions. The United States Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare related products and provides pharmaceutical solutions to life sciences companies. European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers. Medical-Surgical Solutions segment distributes medical-surgical supplies and provides logistics and other services to healthcare providers.
Company Coordinates stock-summary
Company Details
6555 State Highway 161 , IRVING TX : 75039-2402
stock-summary
Tel: 1 972 4464800
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 189 Schemes (34.68%)

Foreign Institutions

Held by 488 Foreign Institutions (24.05%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Edward Mueller
Independent Chairman of the Board
Mr. Brian Tyler
Chief Executive Officer, Director
Mr. Dominic Caruso
Independent Director
Dr. N. Anthony Coles
Independent Director
Ms. Christine Jacobs
Independent Director
Mr. Donald Knauss
Independent Director
Ms. Marie Knowles
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
97,827 Million
(Quarterly Results - Jun 2025)
Net Profit:
831 Million
stock-summary
Industry

Retailing

stock-summary
Market cap

USD 171,725 Million (Large Cap)

stock-summary
P/E

56.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

23.17%

stock-summary
Debt Equity

-2.74

stock-summary
Return on Equity

-152.50%

stock-summary
Price to Book

-87.30